Reliq Health Technologies (RHT.V) – anticipating a great 2019 #2

Timing is an extremely difficult thing in equity markets.  That is why investors generally shouldn’t worry unduly when they don’t get it exactly right.  What is more important is to have a solid prospect that will yield positive returns over time. Continue reading “Reliq Health Technologies (RHT.V) – anticipating a great 2019 #2”

Reliq Health Technologies (RHT.V) – setting expectations

RHT.V has been making great progress with clients and getting patients onboard.  News regarding newly added users has a significant impact upon the stock price.  The company has also ramped up its sales force, and training of client staff, responsible for working directly with patients, is ongoing. Continue reading “Reliq Health Technologies (RHT.V) – setting expectations”

Reliq Health Technologies (RHT.V) – Nasdaq listing plans and change to risk rating

Themoneynarrative reader Jean-Pierre asked a great question about the likelihood of RHT.V obtaining a Nasdaq listing.  We communicated with CEO Lisa Crossley, who had the following to say: Continue reading “Reliq Health Technologies (RHT.V) – Nasdaq listing plans and change to risk rating”

Reliq Health Technologies (RHT.V) – November 22, 2017 presentations

Themoneynarrative arranged for investment advisors at Echelon Wealth Partners in Montreal to meet RHT.V’s CEO, Lisa Crossley, last Wednesday (November 22, 2017).  Later that day, Lisa presented before a larger group of investors at an event hosted by Paul Benwell & Associates, corporate market awareness and introductions counsel Continue reading “Reliq Health Technologies (RHT.V) – November 22, 2017 presentations”